Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
The hospital in association with ‘We Warriors’ and ‘Dev Bhumi Rakshak Foundation’ organized First Aid and CPR training session for youngsters and volunteers
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
The generous donation includes multiple medical equipments
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Subscribe To Our Newsletter & Stay Updated